Omron Corp. (OTCMKTS:OMRNY - Get Free Report)'s share price reached a new 52-week low on Tuesday . The company traded as low as $24.16 and last traded at $24.36, with a volume of 113940 shares. The stock had previously closed at $25.71.
Omron Price Performance
The company has a current ratio of 2.31, a quick ratio of 1.57 and a debt-to-equity ratio of 0.13. The firm's 50-day moving average price is $26.91 and its 200-day moving average price is $29.31. The stock has a market capitalization of $5.73 billion, a PE ratio of 49.63 and a beta of 1.04.
Omron (OTCMKTS:OMRNY - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.11). Omron had a net margin of 2.07% and a return on equity of 1.75%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.48 billion. On average, equities analysts forecast that Omron Corp. will post 0.42 EPS for the current fiscal year.
Institutional Trading of Omron
A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its stake in Omron Corp. (OTCMKTS:OMRNY - Free Report) by 831.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,946 shares of the company's stock after buying an additional 13,342 shares during the period. GAMMA Investing LLC's holdings in Omron were worth $421,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 1.09% of the company's stock.
About Omron
(
Get Free Report)
OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.
Featured Articles
Before you consider Omron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.
While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
